According to Seres Therapeutics's latest financial reports the company's current earnings (TTM) are -HK$1.14 B. In 2023 the company made an earning of -HK$0.79 B an increase over its 2022 earnings that were of -HK$1.91 B.The earnings displayed on this page is the company's Pretax Income.